Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.

CompletedOBSERVATIONAL

Enrollment

847

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

March 12, 2021

Study Completion Date

March 12, 2021

Conditions

Breast Cancer Metastatic

Trial Locations (2)

Pfizer country office, Buenos Aires

Adelphi Mill, Bollington, Cheshire, SK10 5JB, UK, Bollington